Trade Summary

6 days ago, Freund John Gordon, serving as Dir at Collegium Pharmaceutical, Inc (COLL), sold 4,127 shares at $34.54 per share, for a total transaction value of $142,547.00. Following this transaction, Freund John Gordon now holds 115,726 shares of COLL.

This sale represents a 3.00% decrease in Freund John Gordon's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 4:15 PM ET, 3 days after the trade was made.

Collegium Pharmaceutical, Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.